Cargando…
Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design
BACKGROUND: Metastatic prostate cancer remains a lethal malignancy that warrants novel supportive interventions for patients and their decision partners and proxies. Decision aids have been applied primarily to patients with localized disease, with minimal inclusion of patients with advanced prostat...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444368/ https://www.ncbi.nlm.nih.gov/pubmed/34530868 http://dx.doi.org/10.1186/s13063-021-05602-0 |
_version_ | 1784568476739829760 |
---|---|
author | Carhuapoma, Lourdes R. Thayer, Winter M. Elmore, Catherine E. Gildersleeve, Jane Singh, Tanmay Shaukat, Farah Uveges, Melissa K. Gray, Tamryn Chu, Crystal Song, Daniel Hollen, Patricia J. Wenzel, Jennifer Jones, Randy A. |
author_facet | Carhuapoma, Lourdes R. Thayer, Winter M. Elmore, Catherine E. Gildersleeve, Jane Singh, Tanmay Shaukat, Farah Uveges, Melissa K. Gray, Tamryn Chu, Crystal Song, Daniel Hollen, Patricia J. Wenzel, Jennifer Jones, Randy A. |
author_sort | Carhuapoma, Lourdes R. |
collection | PubMed |
description | BACKGROUND: Metastatic prostate cancer remains a lethal malignancy that warrants novel supportive interventions for patients and their decision partners and proxies. Decision aids have been applied primarily to patients with localized disease, with minimal inclusion of patients with advanced prostate cancer and their decision partners. The use of a community patient navigator (CPN) has been shown to have a positive supportive role in health care, particularly with individuals from minority populations. Research is needed to evaluate decision support interventions tailored to the needs of advanced prostate cancer patients and their decision partners in diverse populations. METHODS: Guided by Janis and Mann’s Conflict Model of Decision Making, the Cancer Health Aid to Manage Preferences and Improve Outcomes through Navigation (CHAMPION) is a randomized controlled trial to assess the feasibility and acceptability of a mobile health (mHealth), CPN-administered decision support intervention designed to facilitate communication between patients, their decision partners, and the healthcare team. Adult prostate cancer patients and their decision partners at three mid-Atlantic hospitals in the USA were randomized to receive enhanced usual care or the decision intervention. The CHAMPION intervention includes a theory-based decision-making process tutorial, immediate and health-related quality of life graphical summaries over time (using mHealth), values clarification via a balance sheet procedure with the CPN support during difficult decisions, and facilitated discussions with providers to enhance informed, shared decision-making. DISCUSSION: The CHAMPION intervention is designed to leverage dynamic resources, such as CPN teams, mHealth technology, and theory-based information, to support decision-making for advanced prostate cancer patients and their decision partners. This intervention is intended to engage decision partners in addition to patients and represents a novel, sustainable, and scalable way to build on individual and community strengths. Patients from minority populations, in particular, may face unique challenges during clinical communication. CHAMPION emphasizes the inclusion of decision partners and CPNs as facilitators to help address these barriers to care. Thus, the CHAMPION intervention has the potential to positively impact patient and decision partner well-being by reducing decisional conflict and decision regret related to complex, treatment-based decisions, and to reduce cancer health disparities. Trial registration ClinicalTrials.govNCT03327103. Registered on 31 October 2017—retrospectively registered. World Health Organization Trial Registration Data Set included in Supplementary Materials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05602-0. |
format | Online Article Text |
id | pubmed-8444368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84443682021-09-16 Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design Carhuapoma, Lourdes R. Thayer, Winter M. Elmore, Catherine E. Gildersleeve, Jane Singh, Tanmay Shaukat, Farah Uveges, Melissa K. Gray, Tamryn Chu, Crystal Song, Daniel Hollen, Patricia J. Wenzel, Jennifer Jones, Randy A. Trials Study Protocol BACKGROUND: Metastatic prostate cancer remains a lethal malignancy that warrants novel supportive interventions for patients and their decision partners and proxies. Decision aids have been applied primarily to patients with localized disease, with minimal inclusion of patients with advanced prostate cancer and their decision partners. The use of a community patient navigator (CPN) has been shown to have a positive supportive role in health care, particularly with individuals from minority populations. Research is needed to evaluate decision support interventions tailored to the needs of advanced prostate cancer patients and their decision partners in diverse populations. METHODS: Guided by Janis and Mann’s Conflict Model of Decision Making, the Cancer Health Aid to Manage Preferences and Improve Outcomes through Navigation (CHAMPION) is a randomized controlled trial to assess the feasibility and acceptability of a mobile health (mHealth), CPN-administered decision support intervention designed to facilitate communication between patients, their decision partners, and the healthcare team. Adult prostate cancer patients and their decision partners at three mid-Atlantic hospitals in the USA were randomized to receive enhanced usual care or the decision intervention. The CHAMPION intervention includes a theory-based decision-making process tutorial, immediate and health-related quality of life graphical summaries over time (using mHealth), values clarification via a balance sheet procedure with the CPN support during difficult decisions, and facilitated discussions with providers to enhance informed, shared decision-making. DISCUSSION: The CHAMPION intervention is designed to leverage dynamic resources, such as CPN teams, mHealth technology, and theory-based information, to support decision-making for advanced prostate cancer patients and their decision partners. This intervention is intended to engage decision partners in addition to patients and represents a novel, sustainable, and scalable way to build on individual and community strengths. Patients from minority populations, in particular, may face unique challenges during clinical communication. CHAMPION emphasizes the inclusion of decision partners and CPNs as facilitators to help address these barriers to care. Thus, the CHAMPION intervention has the potential to positively impact patient and decision partner well-being by reducing decisional conflict and decision regret related to complex, treatment-based decisions, and to reduce cancer health disparities. Trial registration ClinicalTrials.govNCT03327103. Registered on 31 October 2017—retrospectively registered. World Health Organization Trial Registration Data Set included in Supplementary Materials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05602-0. BioMed Central 2021-09-16 /pmc/articles/PMC8444368/ /pubmed/34530868 http://dx.doi.org/10.1186/s13063-021-05602-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Carhuapoma, Lourdes R. Thayer, Winter M. Elmore, Catherine E. Gildersleeve, Jane Singh, Tanmay Shaukat, Farah Uveges, Melissa K. Gray, Tamryn Chu, Crystal Song, Daniel Hollen, Patricia J. Wenzel, Jennifer Jones, Randy A. Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design |
title | Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design |
title_full | Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design |
title_fullStr | Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design |
title_full_unstemmed | Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design |
title_short | Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design |
title_sort | employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the champion randomized controlled trial study design |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444368/ https://www.ncbi.nlm.nih.gov/pubmed/34530868 http://dx.doi.org/10.1186/s13063-021-05602-0 |
work_keys_str_mv | AT carhuapomalourdesr employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT thayerwinterm employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT elmorecatherinee employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT gildersleevejane employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT singhtanmay employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT shaukatfarah employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT uvegesmelissak employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT graytamryn employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT chucrystal employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT songdaniel employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT hollenpatriciaj employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT wenzeljennifer employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign AT jonesrandya employingamobilehealthdecisionaidtoimprovedecisionmakingforpatientswithadvancedprostatecancerandtheirdecisionpartnersproxiesthechampionrandomizedcontrolledtrialstudydesign |